Indoline amide derivatives as EP4 receptor ligands

Details for Australian Patent Application No. 2007260529 (hide)

Owner Merck Frosst Canada Ltd.

Inventors Colucci, John; Boyd, Michael

Agent Spruson & Ferguson

Pub. Number AU-B-2007260529

PCT Pub. Number WO2007/143825

Priority 60/812,742 12.06.06 US

Filing date 8 June 2007

Wipo publication date 21 December 2007

Acceptance publication date 19 April 2012

International Classifications

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/404 (2006.01)

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

Event Publications

18 December 2008 PCT application entered the National Phase

  PCT publication WO2007/143825 Priority application(s): WO2007/143825

19 April 2012 Application Accepted

  Published as AU-B-2007260529

16 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007260532-Nozzle testing apparatus and method

2007260528-Azacyclopentane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase